Russell Clayton
Patrimonio netto: 248 622 $ in data 31/05/2026
Patrimonio netto: 248 622 $ in data 31/05/2026
Russell G.
Clayton is currently Chief Medical Officer at Larimar Therapeutics, Inc. since 2023.
Former positions include Regional Medical Director-Scientific Affairs at Merck & Co., Inc., Director-Asthma Program Division at The Children's Hospital of Philadelphia Foundation, Chief Medical Officer at Alcresta Therapeutics, Inc. from 2015 to 2017, and Senior Vice President-Research & Development at Windtree Therapeutics, Inc. from 2011 to 2014.
Education includes undergraduate studies at LaSalle University and a doctorate from Philadelphia College of Osteopathic Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 26/01/2026 | 71.443 ( 0,08% ) | 248 622 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 17/07/2023 |
| Società | Posizione | Fine |
|---|---|---|
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Direttore Tecnico/Scientifico/R&S | 01/04/2017 |
| WINDTREE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2014 |
The Children's Hospital of Philadelphia Foundation
The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services Provides health care services | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Windtree Therapeutics, Inc.
Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets | Health Technology |
LaSalle University
LaSalle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Hospital of Philadelphia Foundation
The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Philadelphia College of Osteopathic Medicine
Philadelphia College of Osteopathic Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops enzyme-based products that deliver enzymatic solutions to those living with rare diseases | Health Technology |
Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale